A Phase I/II trial comparing autologous dendritic cell vaccine pulsed either with personalized peptides (PEP-DC) or with tumor lysate (OC-DC) in patients with advanced high-grade ovarian serous…

Overview of attention for article published in Journal of Translational Medicine, November 2019

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 45 Dimensions

Readers on

mendeley: 48 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 81 followers.

A Phase I/II trial comparing autologous dendritic cell vaccine pulsed either with personalized peptides (PEP-DC) or with tumor lysate (OC-DC) in patients with advanced high-grade ovarian serous carcinoma. https://t.co/cMo8fMXdlJ

28 Nov 2019

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.